Insider Trading November 11, 2026 12:01 AM

Hilton EVP Silcock Offloads $5.7 Million in Stock After Option Exercise

The insider sale arrives as Hilton shares hover near a 52-week high, with valuation metrics signaling potential overvaluation.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
HLT

Christopher W. Silcock, Executive Vice President at Hilton Worldwide Holdings Inc. (NYSE:HLT), sold 15,638 shares for approximately $5.79 million on November 6, 2026, following the exercise of employee stock options. The sale occurred at prices between $370.13 and $370.52 per share, with a weighted average of $370.172. Silcock exercised options at $58.02 per share, acquiring the shares for about $907,316. After the transactions, he directly holds 88,257 shares and no longer holds any derivative securities in the form of employee stock options. The sale comes as Hilton shares trade at $379.76, just 1% below their 52-week high of $381.34, after a 32% year-to-date gain and a 39% return over the past year. The stock appears overvalued based on a Fair Value assessment and trades at a P/E ratio of 51. Hilton recently reported third-quarter 2026 adjusted earnings of $2.45 per share, surpassing the $2.35 forecast, while revenue of $3.33 billion slightly missed the $3.36 billion estimate. System-wide revenue per available room rose 5.8%, prompting an upward revision to the full-year RevPAR outlook. Analyst actions include a Mizuho upgrade to Outperform with a $421 price target, an Argus price target increase to $410, a Goldman Sachs reiterated Buy with a $390 target, and Morgan Stanley maintaining Overweight with a $362 target.

Hilton EVP Silcock Offloads $5.7 Million in Stock After Option Exercise
HLT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Hilton EVP Christopher W. Silcock sold 15,638 shares for $5.79 million after exercising options at $58.02 per share, leaving him with 88,257 shares and no remaining options.
  • The sale occurs as Hilton shares trade near their 52-week high of $381.34, with a P/E ratio of 51 and a Fair Value assessment indicating overvaluation.
  • Hilton's Q3 2026 adjusted EPS beat estimates, but revenue fell short; the company raised its full-year RevPAR outlook on a 5.8% system-wide RevPAR increase.
  • Analyst actions are mixed: Mizuho upgraded to Outperform with a $421 target, Argus raised its target to $410, Goldman Sachs reiterated Buy with a $390 target, and Morgan Stanley maintained Overweight with a $362 target.

Christopher W. Silcock, Executive Vice President at Hilton Worldwide Holdings Inc. (NYSE:HLT), sold 15,638 shares of common stock for approximately $5.79 million on November 6, 2026, according to a regulatory filing. The shares were sold at prices ranging from $370.13 to $370.52, with a weighted average price of $370.172.

The transaction followed Silcock's exercise of employee stock options, through which he acquired the same number of shares. The options were exercised at $58.02 per share, for a total cost of about $907,316. These options had vested in three equal annual installments beginning February 27, 2018. Following the exercise and sale, Silcock directly holds 88,257 shares of Hilton common stock and no longer holds any derivative securities in the form of employee stock options.

The insider sale comes as Hilton shares trade at $379.76, just 1% below their 52-week high of $381.34. The stock has delivered a 32% gain year-to-date and a 39% return over the past year. Based on a Fair Value assessment, the stock currently appears overvalued, while trading at a P/E ratio of 51.

In other recent developments, Hilton reported third-quarter 2026 earnings that surpassed Wall Street's expectations with adjusted earnings of $2.45 per share compared to the forecasted $2.35. However, revenue of $3.33 billion slightly missed the anticipated $3.36 billion. Despite the revenue shortfall, Hilton experienced a 5.8% increase in system-wide revenue per available room, attributed to stronger business and group travel, and subsequently raised its full-year RevPAR outlook.

Analyst ratings have also seen adjustments. Mizuho upgraded Hilton to Outperform from Neutral, raising its price target to $421, highlighting the company's high-quality business model. Argus increased its price target to $410 from $400, maintaining a Buy rating based on Hilton's growth prospects and capital structure. Goldman Sachs reiterated a Buy rating with a $390 price target, noting a slight underperformance in net unit growth pacing. Morgan Stanley maintained its Overweight rating with a $362 price target. These developments reflect a blend of positive earnings performance and varied analyst perspectives on Hilton's future growth trajectory.

Risks

  • The stock's premium valuation, with a P/E of 51 and a Fair Value assessment suggesting overvaluation, could lead to a price correction if growth slows or market sentiment shifts.
  • Revenue missed analyst estimates in Q3 2026, and a continued shortfall could pressure the stock despite strong RevPAR trends.
  • Insider selling, such as the $5.7 million sale by EVP Silcock, may be interpreted by some investors as a lack of confidence, potentially affecting shares in the consumer discretionary sector.

More from Insider Trading

HCA Healthcare's Chief Nurse Executive Offloads $1.77 Million in Shares Nov 11, 2026 Drilling Tools International CEO Robert Prejean Buys 100,000 Shares for $164,300 Nov 11, 2026 Kontoor Brands Executive Sells Shares Worth $511,803 Nov 11, 2026 Aware CEO Ajay Amlani Purchases 4,000 Shares as Stock Trades Below $1 Nov 11, 2026 Floor & Decor EVP Ersan Sayman Offloads $1.11M in Stock Nov 11, 2026